![Michelle Werner](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Michelle Werner
Corporate Officer/Principal at
IPSEN
Profile
Michelle C.
Werner is Executive Vice President & President-North America at Ipsen SA since 2026.
Former roles include Chief Executive Officer & Director at Alltrna from 2022 to 2026, Independent Director at Omega Therapeutics, Inc. from 2023 to 2024, Director at Channel One, Inc., Head-Worldwide Franchise at Novartis Oncology, Inc. from 2020 to 2022, VP & Head-Global Haematology Franchise at AstraZeneca PLC in 2020, and US Brand Lead, Reyataz at Bristol Myers Squibb Co. from 2014 to 2015.
Education includes an undergraduate degree from the University of Pennsylvania in 1997 and an MBA from London Business School in 2005.
Michelle Werner active positions
| Companies | Position | Start |
|---|---|---|
| IPSEN | Corporate Officer/Principal | 2026-03-22 |
Former positions of Michelle Werner
| Companies | Position | End |
|---|---|---|
Alltrna
 Alltrna Pharmaceuticals: MajorHealth Technology Develops tRNA-based medicines for genetic disorders | Chief Executive Officer | 2026-03-05 |
| OMEA THER | Director/Board Member | 2024-12-29 |
Novartis Oncology, Inc.
 Novartis Oncology, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets health care and nutritional products | Corporate Officer/Principal | 2022-03-31 |
| ASTRAZENECA PLC | Corporate Officer/Principal | 2020-07-01 |
| BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | 2015-05-01 |
Training of Michelle Werner
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
98
1st degree connections
9
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 9 |
|---|---|
Bristol Myers Squibb Co.
 Bristol Myers Squibb Co. Pharmaceuticals: MajorHealth Technology Manufactures and markets biopharmaceuticals products | Health Technology |
AstraZeneca PLC
 AstraZeneca PLC Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Novartis Oncology, Inc.
Novartis Oncology, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets health care and nutritional products | Health Technology |
Ipsen SA
 Ipsen SA Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
University of Pennsylvania
 University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
London Business School
 London Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Channel One, Inc.
 Channel One, Inc. Services to the Health IndustryHealth Services Provides social services | Health Services |
Omega Therapeutics, Inc.
 Omega Therapeutics, Inc. BiotechnologyHealth Technology Develops therapeutics for general and rare genetic diseases, immunology, inflammation, oncology and metabolic diseases | Health Technology |
Alltrna
Alltrna Pharmaceuticals: MajorHealth Technology Develops tRNA-based medicines for genetic disorders | Health Technology |
- Stock Market
- Insiders
- Michelle Werner
